vs
Cooper Companies (The)（COO）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是Rollins, Inc.的1.2倍（$1.1B vs $906.4M），Rollins, Inc.净利率更高（11.9% vs 7.9%，领先4.0%），Rollins, Inc.同比增速更快（10.2% vs 4.6%），Cooper Companies (The)自由现金流更多（$149.9M vs $111.2M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 0.8%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
COO vs ROL — 直观对比
营收规模更大
COO
是对方的1.2倍
$906.4M
营收增速更快
ROL
高出5.6%
4.6%
净利率更高
ROL
高出4.0%
7.9%
自由现金流更多
COO
多$38.7M
$111.2M
两年增速更快
COO
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $906.4M |
| 净利润 | $84.6M | $107.8M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | 16.1% |
| 净利率 | 7.9% | 11.9% |
| 营收同比 | 4.6% | 10.2% |
| 净利润同比 | -28.0% | 2.5% |
| 每股收益（稀释后） | $0.42 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.1B | $912.9M | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $1.0B | $999.5M | ||
| Q1 25 | $964.7M | $822.5M | ||
| Q4 24 | $1.0B | $832.2M | ||
| Q3 24 | $1.0B | $916.3M | ||
| Q2 24 | $942.6M | $891.9M |
净利润COOROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $84.6M | $116.4M | ||
| Q3 25 | $98.3M | $163.5M | ||
| Q2 25 | $87.7M | $141.5M | ||
| Q1 25 | $104.3M | $105.2M | ||
| Q4 24 | $117.5M | $105.7M | ||
| Q3 24 | $104.7M | $136.9M | ||
| Q2 24 | $88.9M | $129.4M |
毛利率COOROL
| Q1 26 | — | — | ||
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — |
营业利润率COOROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 13.2% | 17.5% | ||
| Q3 25 | 16.6% | 21.9% | ||
| Q2 25 | 18.4% | 19.8% | ||
| Q1 25 | 18.9% | 17.3% | ||
| Q4 24 | 19.5% | 18.1% | ||
| Q3 24 | 19.2% | 20.9% | ||
| Q2 24 | 17.2% | 20.4% |
净利率COOROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | 7.9% | 12.8% | ||
| Q3 25 | 9.3% | 15.9% | ||
| Q2 25 | 8.7% | 14.2% | ||
| Q1 25 | 10.8% | 12.8% | ||
| Q4 24 | 11.5% | 12.7% | ||
| Q3 24 | 10.4% | 14.9% | ||
| Q2 24 | 9.4% | 14.5% |
每股收益（稀释后）COOROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $0.42 | $0.24 | ||
| Q3 25 | $0.49 | $0.34 | ||
| Q2 25 | $0.44 | $0.29 | ||
| Q1 25 | $0.52 | $0.22 | ||
| Q4 24 | $0.59 | $0.22 | ||
| Q3 24 | $0.52 | $0.28 | ||
| Q2 24 | $0.44 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $116.5M |
| 总债务越低越好 | $2.5B | $650.6M |
| 股东权益账面价值 | $8.2B | $1.4B |
| 总资产 | $12.4B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资COOROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $110.6M | $100.0M | ||
| Q3 25 | $124.9M | $127.4M | ||
| Q2 25 | $116.2M | $123.0M | ||
| Q1 25 | $100.9M | $201.2M | ||
| Q4 24 | $107.6M | $89.6M | ||
| Q3 24 | $109.7M | $95.3M | ||
| Q2 24 | $112.4M | $106.7M |
总债务COOROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | $2.5B | $486.1M | ||
| Q3 25 | $2.4B | $485.7M | ||
| Q2 25 | $2.5B | $485.3M | ||
| Q1 25 | $2.5B | $485.5M | ||
| Q4 24 | $2.6B | $395.3M | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — |
股东权益COOROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $8.2B | $1.4B | ||
| Q3 25 | $8.4B | $1.5B | ||
| Q2 25 | $8.3B | $1.4B | ||
| Q1 25 | $8.1B | $1.4B | ||
| Q4 24 | $8.1B | $1.3B | ||
| Q3 24 | $7.9B | $1.3B | ||
| Q2 24 | $7.8B | $1.2B |
总资产COOROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $12.4B | $3.1B | ||
| Q3 25 | $12.4B | $3.2B | ||
| Q2 25 | $12.4B | $3.2B | ||
| Q1 25 | $12.2B | $2.9B | ||
| Q4 24 | $12.3B | $2.8B | ||
| Q3 24 | $12.1B | $2.8B | ||
| Q2 24 | $12.0B | $2.8B |
负债/权益比COOROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | 0.30× | 0.35× | ||
| Q3 25 | 0.29× | 0.32× | ||
| Q2 25 | 0.30× | 0.34× | ||
| Q1 25 | 0.31× | 0.36× | ||
| Q4 24 | 0.32× | 0.30× | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $111.2M |
| 自由现金流率自由现金流/营收 | 14.1% | 12.3% |
| 资本支出强度资本支出/营收 | 9.2% | 0.8% |
| 现金转化率经营现金流/净利润 | 2.93× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $433.7M | $621.1M |
8季度趋势，按日历期对齐
经营现金流COOROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $247.9M | $164.7M | ||
| Q3 25 | $261.4M | $191.3M | ||
| Q2 25 | $96.2M | $175.1M | ||
| Q1 25 | $190.6M | $146.9M | ||
| Q4 24 | $268.1M | $188.2M | ||
| Q3 24 | $207.5M | $146.9M | ||
| Q2 24 | $111.0M | $145.1M |
自由现金流COOROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $149.9M | $159.0M | ||
| Q3 25 | $164.5M | $182.8M | ||
| Q2 25 | $18.1M | $168.0M | ||
| Q1 25 | $101.2M | $140.1M | ||
| Q4 24 | $128.1M | $184.0M | ||
| Q3 24 | $118.5M | $139.4M | ||
| Q2 24 | $36.9M | $136.4M |
自由现金流率COOROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 14.1% | 17.4% | ||
| Q3 25 | 15.5% | 17.8% | ||
| Q2 25 | 1.8% | 16.8% | ||
| Q1 25 | 10.5% | 17.0% | ||
| Q4 24 | 12.6% | 22.1% | ||
| Q3 24 | 11.8% | 15.2% | ||
| Q2 24 | 3.9% | 15.3% |
资本支出强度COOROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 9.2% | 0.6% | ||
| Q3 25 | 9.1% | 0.8% | ||
| Q2 25 | 7.8% | 0.7% | ||
| Q1 25 | 9.3% | 0.8% | ||
| Q4 24 | 13.7% | 0.5% | ||
| Q3 24 | 8.9% | 0.8% | ||
| Q2 24 | 7.9% | 1.0% |
现金转化率COOROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 2.93× | 1.41× | ||
| Q3 25 | 2.66× | 1.17× | ||
| Q2 25 | 1.10× | 1.24× | ||
| Q1 25 | 1.83× | 1.40× | ||
| Q4 24 | 2.28× | 1.78× | ||
| Q3 24 | 1.98× | 1.07× | ||
| Q2 24 | 1.25× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
ROL
暂无分部数据
